|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-11-30
|
|
pubmed:abstractText |
Measuring antibodies to Bordetella pertussis antigens is mostly done by enzyme-linked immunosorbent assays (ELISAs). We compared the performance of ELISA kits that were commercially available in Germany. Eleven measured IgG antibodies, and nine measured IgA antibodies. An in-house ELISA with purified antigens served as a reference method. Samples included two WHO reference preparations, the former Food and Drug Administration (FDA)/Center for Biologics Evaluation and Research (CBER) reference preparations, serum samples from patients with clinically suspected pertussis, and serum samples from patients having received a combined tetanus, diphtheria, and pertussis (Tdap) vaccination. Kits using pertussis toxin (PT) as an antigen showed linearity compared to the WHO Reference preparation (r2 between 0.82 and 0.99), and these kits could quantify antibodies according to the reference preparation. ELISA kits using mixed antigens showed no linear correlation to the reference preparations. Patient results were compared to results of in-house ELISAs using a dual cutoff of either ?100 IU/ml anti-PT IgG or ?40 IU/ml anti-PT IgG together with ?12 IU/ml anti-PT IgA. The sensitivities of kits measuring IgG antibodies ranged between 0.84 and 1.00. The specificities of kits using PT as an antigen were between 0.81 and 0.93. The specificities of kits using mixed antigens were between 0.51 and 0.59 and were thus not acceptable. The sensitivities of kits measuring IgA antibodies ranged between 0.53 and 0.73, and the specificities were between 0.67 and 0.94, indicating that IgA antibodies may be of limited diagnostic value. Our data suggest that ELISAs should use purified PT as an antigen and be standardized to the 1st International Reference preparation.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-10421041,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-10655388,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-11023464,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-15539504,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-15724723,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-15816147,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-15831828,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-16050521,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-16356597,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-16779740,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-17989336,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-18321880,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-18367565,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-18407287,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-18602434,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-19109448,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-19864485,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-2019753,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-8243485,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20943873-8914760
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1098-660X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4459-63
|
|
pubmed:dateRevised |
2011-7-28
|
|
pubmed:meshHeading |
pubmed-meshheading:20943873-Adolescent,
pubmed-meshheading:20943873-Adult,
pubmed-meshheading:20943873-Antibodies, Bacterial,
pubmed-meshheading:20943873-Bordetella pertussis,
pubmed-meshheading:20943873-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20943873-Germany,
pubmed-meshheading:20943873-Humans,
pubmed-meshheading:20943873-Immunoglobulin A,
pubmed-meshheading:20943873-Immunoglobulin G,
pubmed-meshheading:20943873-Pertussis Vaccine,
pubmed-meshheading:20943873-Reagent Kits, Diagnostic,
pubmed-meshheading:20943873-Sensitivity and Specificity,
pubmed-meshheading:20943873-Whooping Cough
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.
|
|
pubmed:affiliation |
Institut for Hygiene and Labormedizin, Zentrum for Kinder-und Jugendmedizin, HELIOS Klinikum Krefeld, Lutherplatz 40, D-47805 Krefeld, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
